You are here

Article Text

Article menu
Download PDFPDF
Case Reports: Reminder of important clinical lesson
Common condition with uncommon cause: fungal folliculitis in immunosuppressed patient with Blau syndrome
  1. Mona Ebadian1,
  2. Antonia Barbieri2 and
  3. Volha Shpadaruk3
  1. 1Dermatology, Northampton General Hospital NHS Trust, Northampton, Northamptonshire, UK
  2. 2Histopathology, Northampton General Hospital NHS Trust, Northampton, Northamptonshire, UK
  3. 3Dermatology, Kettering General Hospital, Kettering, UK
  1. Correspondence to Dr Mona Ebadian; monaebadian{at}hotmail.com

Abstract

We present a case of a patient with a history of Blau syndrome, who presented with acute onset of widespread florid painful folliculitis rash, which was resistant to the treatment with multiple courses of antibiotics in the community. Despite of the negative skin swab and negative periodic acid-schiff (PAS)stain on the skin biopsy, clinical diagnosis was fungal folliculitis and patient responded well to the course of itraconazole.

  • Dermatology
  • Skin

https://doi.org/10.1136/bcr-2021-243565

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Contributors ME: 1st author review of patient and management, followed up the case and discussed with seniors, read up on this case and its management, wrote up the case report and submitted this case to BMJ. AB: biopsy report and review of the histopathology report section of this article. VS: supervision of this case both clinically and case report review.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Case reports provide a valuable learning resource for the scientific community and can indicate areas of interest for future research. They should not be used in isolation to guide treatment choices or public health policy.

    • Competing interests None declared.

    • Provenance and peer review Not commissioned; externally peer reviewed.